ClinicalTrialsFinder
RecruitingNCT05632419

Prognosis of Patients Who Presented With a State of Extreme Agitation.

Assess the 6-month Prognosis of Patients Who Presented With a State of Extreme Agitation: "Excited Delirium Syndrome" AGICOHORT

Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment

608 participants

Start Date

Jan 17, 2023

Study Type

OBSERVATIONAL

Conditions

Emergence Delirium

Summary

The main objective is to assess the 6-month prognosis of patients who presented with extreme agitation in the emergency room. The primary endpoint is the 6-month mortality of agitated patients.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with emergence delirium. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

Avicenne Hospital - Aphp

Bobigny, Île-de-France Region, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05632419

Related Trials

Post Operative Cognitive Dysfunction After Breast Surgery

NCT037744201 location

The Occurrence of Emergence Agitation in Pediatric Strabismus Surgery

NCT060357571 location

Dexmedetomidine-Midazolam vs. Ketamine-Midazolam on Emergence Delirium

NCT074274461 location

Efficacy of Ultrasound-guided Greater Auricular Nerve Block in Preventing Postoperative Emergence Agitation in Pediatric Patients Undergoing Microscopic Middle Ear Surgery.

NCT074356751 location

Language During Inhalational Induction

NCT063249551 location